Literature DB >> 23622139

Genetic risk factors for pancreatic disorders.

David C Whitcomb1.   

Abstract

A combination of genetic, environmental, and metabolic factors contribute to the development and recurrence of acute and chronic pancreatitis; information on all of these is required to manage patients effectively. For example, variants that affect regulation of the protease, serine (PRSS)1-PRSS2, and claudin (CLDN)2 loci, rather than their coding sequences, interact with other genetic and environmental factors to affect disease development. New strategies are needed to use these data and determine their contribution to pathogenesis, because these variants differ from previously studied, rare variants in exons (coding regions) of genes such as PRSS1, SPINK1, cystic fibrosis transmembrane conductance regulator (CFTR), chymotrypsin (CTR)C, and calcium-sensing receptor (CASR). Learning how various genetic factors affect pancreatic cells and systems could lead to etiology-based therapies rather than treatment of symptoms.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23622139      PMCID: PMC3684061          DOI: 10.1053/j.gastro.2013.01.069

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  121 in total

1.  Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis.

Authors:  Chee Y Ooi; Ruslan Dorfman; Marco Cipolli; Tanja Gonska; Carlo Castellani; Katherine Keenan; Steven D Freedman; Julian Zielenski; Yves Berthiaume; Mary Corey; Susanne Schibli; Elizabeth Tullis; Peter R Durie
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

2.  Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis.

Authors:  Raghuwansh P Sah; Suresh T Chari; Rahul Pannala; Aravind Sugumar; Jonathan E Clain; Michael J Levy; Randall K Pearson; Thomas C Smyrk; Bret T Petersen; Mark D Topazian; Naoki Takahashi; Michael B Farnell; Santhi S Vege
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

3.  Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis.

Authors:  Kwang Hyuck Lee; Ji Kon Ryu; Won Jae Yoon; Jun Kyu Lee; Yong-Tae Kim; Yong Bum Yoon
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

4.  Dynamic regulation of CFTR bicarbonate permeability by [Cl-]i and its role in pancreatic bicarbonate secretion.

Authors:  Hyun Woo Park; Joo Hyun Nam; Joo Young Kim; Wan Namkung; Jae Seok Yoon; Jung-Soo Lee; Kyung Sik Kim; Viktoria Venglovecz; Michael A Gray; Kyung Hwan Kim; Min Goo Lee
Journal:  Gastroenterology       Date:  2010-04-14       Impact factor: 22.682

Review 5.  Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions.

Authors:  Günter Klöppel; Sönke Detlefsen; Suresh T Chari; Daniel S Longnecker; Giuseppe Zamboni
Journal:  J Gastroenterol       Date:  2010-06-12       Impact factor: 7.527

6.  The tetra-aspartate motif in the activation peptide of human cationic trypsinogen is essential for autoactivation control but not for enteropeptidase recognition.

Authors:  Zsófia Nemoda; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2005-06-21       Impact factor: 5.157

7.  Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins.

Authors:  Claire Jacob; Ping-Chang Yang; Dalila Darmoul; Silvia Amadesi; Toshiyuki Saito; Graeme S Cottrell; Anne-Marie Coelho; Pamela Singh; Eileen F Grady; Mary Perdue; Nigel W Bunnett
Journal:  J Biol Chem       Date:  2005-07-18       Impact factor: 5.157

8.  A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis.

Authors:  Kristina K Hansen; Philip M Sherman; Laurie Cellars; Patricia Andrade-Gordon; Zhengying Pan; Amos Baruch; John L Wallace; Morley D Hollenberg; Nathalie Vergnolle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-26       Impact factor: 11.205

9.  A mouse model of ethanol dependent pancreatic fibrosis.

Authors:  G Perides; X Tao; N West; A Sharma; M L Steer
Journal:  Gut       Date:  2005-05-03       Impact factor: 23.059

10.  Protection against acute pancreatitis by activation of protease-activated receptor-2.

Authors:  Anupriya Sharma; Xiaohong Tao; Arun Gopal; Brooke Ligon; Patricia Andrade-Gordon; Michael L Steer; George Perides
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-09-30       Impact factor: 4.052

View more
  92 in total

1.  Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras.

Authors:  Kinji Asahina; Steven Balog; Edward Hwang; Eugene Moon; Emily Wan; Kaitlin Skrypek; Yibu Chen; Jay Fernandez; Janet Romo; Qihong Yang; Keane Lai; Samuel W French; Hidekazu Tsukamoto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-25       Impact factor: 4.052

2.  Risk Factors for Rapid Progression From Acute Recurrent to Chronic Pancreatitis in Children: Report From INSPPIRE.

Authors:  Quin Y Liu; Maisam Abu-El-Haija; Sohail Z Husain; Bradley Barth; Melena Bellin; Douglas S Fishman; Steven D Freedman; Cheryl E Gariepy; Matthew J Giefer; Tanja Gonska; Melvin B Heyman; Ryan Himes; Tom K Lin; Asim Maqbool; Maria Mascarenhas; Brian A McFerron; Veronique D Morinville; Jaimie D Nathan; Chee Y Ooi; Emily R Perito; John F Pohl; Sue Rhee; Sarah J Schwarzenberg; Uzma Shah; David Troendle; Steven L Werlin; Michael Wilschanski; M Bridget Zimmerman; Mark E Lowe; Aliye Uc
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-08       Impact factor: 2.839

Review 3.  Pediatric Autologous Islet Transplantation.

Authors:  Melena D Bellin; Sarah J Schwarzenberg; Marie Cook; David E R Sutherland; Srinath Chinnakotla
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 4.  [Treatment of acute necrotizing pancreatitis].

Authors:  Wolfgang Huber; Hana Algül
Journal:  Internist (Berl)       Date:  2019-03       Impact factor: 0.743

5.  Elastase 3B mutation links to familial pancreatitis with diabetes and pancreatic adenocarcinoma.

Authors:  Paul C Moore; Jessica T Cortez; Chester E Chamberlain; Diana Alba; Amy C Berger; Zoe Quandt; Alice Chan; Mickie H Cheng; Jhoanne L Bautista; Justin Peng; Michael S German; Mark S Anderson; Scott A Oakes
Journal:  J Clin Invest       Date:  2019-08-01       Impact factor: 14.808

6.  Trypsin activity governs increased susceptibility to pancreatitis in mice expressing human PRSS1R122H.

Authors:  Fu Gui; Yuebo Zhang; Jianhua Wan; Xianbao Zhan; Yao Yao; Yinghua Li; Ashley N Haddock; Ji Shi; Jia Guo; Jiaxiang Chen; Xiaohui Zhu; Brandy H Edenfield; Lu Zhuang; Cheng Hu; Ying Wang; Debabrata Mukhopadhyay; Evette S Radisky; Lizhi Zhang; Aurelia Lugea; Stephen J Pandol; Yan Bi; Baoan Ji
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

Review 7.  Cholecystokinin and pancreatic cancer: the chicken or the egg?

Authors:  Jill P Smith; Travis E Solomon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-31       Impact factor: 4.052

8.  Pancreas-specific plasma amylase for assessment and diagnosis of chronic pancreatitis: New insights on an old topic.

Authors:  Søren Schou Olesen; Henrik Krarup; Jakob Lykke Poulsen; Jeppe Hagstrup Christensen; Andrea Rhiannon Glynne Sheel; Robert Sutton; William Greenhalf; Christopher Halloran; Asbjørn Mohr Drewes
Journal:  United European Gastroenterol J       Date:  2019-04-16       Impact factor: 4.623

Review 9.  Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Authors:  Phil A Hart; Melena D Bellin; Dana K Andersen; David Bradley; Zobeida Cruz-Monserrate; Christopher E Forsmark; Mark O Goodarzi; Aida Habtezion; Murray Korc; Yogish C Kudva; Stephen J Pandol; Dhiraj Yadav; Suresh T Chari
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-10-12

10.  The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.

Authors:  Chris E Forsmark; Gong Tang; Hongzhi Xu; Marie Tuft; Steven J Hughes; Dhiraj Yadav
Journal:  Aliment Pharmacol Ther       Date:  2020-04-06       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.